HALO
Halozyme Therapeutics Inc
Price:  
44.71 
USD
Volume:  
1,102,058.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Probability of Bankruptcy

The Probability of Bankruptcy of Halozyme Therapeutics Inc (HALO) is 9.72% . This number represents the probability that HALO will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating HALO's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

HALO - ESG ratings

ESG ratings are directly linked to the cost of capital and HALO's ability to raise funding, both of which can significantly affect the probability of Halozyme Therapeutics Inc going bankrupt.

ESG Score 88.85
Environment Score 99.00
Social Score 99.00
Governance Score 68.54
Returns
Historical Returns (5 day) 2.52%
Historical Returns (MTD) 17.35%
Historical Returns (YTD) 20.97%
Historical Returns (13 week) 24.51%
Historical Returns (26 week) 20.03%
Historical Returns (52 week) 34.26%
Efficiency
Asset Turnover 0.47
Receiveable Turnover 4.42
Gross Margin 85.54%
Operating Margin 48.78%
Pretax Margin 49.02%
Net Margin 39.22%
Return on Asset (ROA) 17.52
Return on Equity (ROE) 192.69
Return on Investments (ROI) 19.16
Price Metrics
Market Cap (M) 5,680.41
Enterprise Value (M)
52 Week High 46.16
52 Week Low 31.86
Beta 1.16
Average Volume (10 day) 1.23
Average Volume (3 month) 1.16
Price / Earnings (P/E) 17.85
Price / Sales (P/S) 6.59
Earnings
EPS 2.42
Revenue CAGR (5 year) 40.42%
Risk
Current Ratio 6.64
Quick Ratio 5.01